Cortigent, Inc.
No enriched coverage for $CRGT in the last 7 days.
No SEC Form 4 filings for $CRGT in the last 30 days.
See all $CRGT insider activity →Vivani Medical’s subsidiary Cortigent will merge with ClearOne, with ClearOne renamed Cortigent Holdings and expected to trade on Nasdaq under ticker CRGT. ClearOne will raise $10M–$15M via concurrent financing. Vivani will receive 12.5M shares and is expected to own 59.4%–67.5% of the combined company; former ClearOne holders 12.7%–14.4%.
Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO), with Cortigent becoming a wholly owned ClearOne unit. ClearOne plans a concurrent $10–15M financing via an S-1. Vivani will receive 12.5M ClearOne shares for 59.4%–67.5% ownership; ClearOne will rename to Cortigent Holdings (CRGT), expected to close Q3 2026.
Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO) via a definitive agreement, making Cortigent a wholly owned ClearOne unit. ClearOne plans a concurrent $10m–$15m financing. Vivani will receive 12.5m ClearOne shares and own 59.4%–67.5%; the combined company will trade as CRGT, expected to close Q3 2026.
CRGT is the post-merger trading vehicle; the market will price the new entity based on deal terms and the underlying neurostimulation pipeline.
CRGT is the post-transaction trading vehicle; the market will likely treat it as a new listing/transition risk until the S-1 and closing occur.
CRGT is the post-transaction trading vehicle; near-term trading will be via CLRO until the name/ticker change occurs.
alphai scores every news story that mentions CRGT with an AI model for sentiment and relevance, and aggregates insider trades from Cortigent, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Vivani Medical’s subsidiary Cortigent will merge with ClearOne, with ClearOne renamed Cortigent Holdings and expected to trade on Nasdaq under ticker CRGT. ClearOne will raise $10M–$15M via concurrent financing. Vivani will receive 12.5M shares and is expected to own 59.4%–67.5% of the combined company; former ClearOne holders 12.7%–14.4%.
4 min readVivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO), with Cortigent becoming a wholly owned ClearOne unit. ClearOne plans a concurrent $10–15M financing via an S-1. Vivani will receive 12.5M ClearOne shares for 59.4%–67.5% ownership; ClearOne will rename to Cortigent Holdings (CRGT), expected to close Q3 2026.
7 min readVivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO) via a definitive agreement, making Cortigent a wholly owned ClearOne unit. ClearOne plans a concurrent $10m–$15m financing. Vivani will receive 12.5m ClearOne shares and own 59.4%–67.5%; the combined company will trade as CRGT, expected to close Q3 2026.
5 min read
